SX-MTR1

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSX-MTR1
Drug Alias NamemTOR modulators (Serometrix)SX-MTR1
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSerometrix LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSerometrix LLC
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A